The U.S. Drug Enforcement Administration is reviewing a recommendation from the Department of Health and Human Services to reclassify cannabis as a Schedule III controlled substance under U.S. law in a move that sparked a rally by cannabis stocks on Wednesday.
The historic move — more than 50 years after the Schedule I designation — could open up cannabis to interstate trade as well as remove an expensive 280E tax burden that prevents legal cannabis companies from writing off normal business expenses, experts said.
A…
This article was originally published by Marketwatch.com. Read the original article here.